Main Article Content

Abstract

Background: Dengue hemorrhagic fever is an infectious ailment that exhibits a significantly elevated incidence rate in Indonesia. Dengue hemorrhagic fever can be classified into primary and secondary infection, where the secondary infection tends to cause more severe clinical manifestations. Hematocrit and platelet count are essential parameters observed in dengue hemorrhagic fever. This study aimed to analysed the existence of statistically significant differences in the level of hematocrit and platelet count between primary and secondary dengue hemorrhagic fever infections.


Methods: This study applied analytical observational cohort design with 60 samples in the form of medical record and laboratory data of hematocrit level and platelet count from patients diagnosed with dengue hemorrhagic fever.


Results: The results reveal significant differences in hematocrit and platelet values between primary and secondary DHF infection. Hematocrit value arises 2.73% higher (p = 0.043) and the platelet count drops 50,500/μl lower (p = 0.00) in secondary dengue hemorrhagic fever infection.


Conclusions: Significant differences of hematocrit and platelet values were found between primary and secondary dengue hemorrhagic infection. Clinicians should increase wary of secondary dengue hemorrhagic fever infected patients due to more severe clinical manifestations.

Keywords

dengue hemorrhagic fever, primary infection, secondary infection, hematocrit, platelet

Article Details

How to Cite
Oscar, J., & Ciptono, F. (2023). The Comparison Between Platelet Count and Hematocrit Levels in Primary and Secondary Dengue Hemorrhagic Fever Infection: Platelet Count and Hematocrit Levels . INDONESIAN JOURNAL OF HEALTH SCIENCES RESEARCH AND DEVELOPMENT (IJHSRD), 5(1), 106–111. https://doi.org/10.36566/ijhsrd/Vol5.Iss1/155

References

  1. World Health Organization. Dengue and Severe Dengue. [updated 2022 Jan 10; cited 2022 Jul 23]. Available from: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue
  2. Guerrant RL. Tropical Infectious Diseases Principle, Pathogens, and Practice. Elsevier. Amsterdam: Elsevier; 2004
  3. Gubler DJ. Dengue and Dengue Hemorrhagic Fever. Wallingford: CABI; 2014
  4. Bhatt P, Sabeena SP, Varma M, Arunkumar G. Current Understanding of the Pathogenesis of Dengue Virus Infection. CurrMicrobiol 78, 17–32 (2021). https://doi.org/10.1007/s00284-020-02284-w
  5. World Health Organization. Comprehensive Guidelines for Prevention and Control of Dengue and Dengue Hemorrhagic Fever. [updated 2016 April; cited 2021 Jul 23]. Available from: https://apps.who.int/iris/handle/10665/204894
  6. DataIndonesia.id. Ada 73.518 Kasus Demam Berdarah Dengue di Indonesia pada 2021 [Cases of Dengue hemorrhagic Fever in Indonesia in 2021]. [updated 2022 August; cited 2022 Dec 7]. Available from: https://dataindonesia.id/ragam/detail/ada-73518-kasus-demam-berdarah-dengue-di-indonesia-pada-2021
  7. World Health Organization. Dengue Bulletin Volume 39, December 2016. [updated 2016 Dec; cited 2022 Jul 21]. Available from: https://apps.who.int/iris/handle/10665/255696
  8. Asih Y, Ester M. Demam Berdarah Dengue Diagnosis, Pengobatan, Pencegahan, dan Pengendalian Edisi 2 [Dengue Hemorrhagic Fever Diagnosis, Treatment, Prevention, and Control 2nd Edition] . Jakarta: Penerbit Buku Kedokteran ECG; 2012
  9. Soegijianto S. Demam Berdarah Dengue Edisi 2 [Dengue Hemorrhagic Fever 2nd Edition]. Surabaya: Pusat Penerbitan dan PercetakanUnair (AUP); 2006
  10. Akbar, M. I., Nurmaladewi, N., Aspian, P., Pagala, I., & Rustam, M. (2022). Assessing the service quality at health service facilities during the COVID-19 pandemic in North Buton District, Indonesia. Public Health of Indonesia, 8(4), 116-122.
  11. Sastroasmoro S. Dasar- Dasar Metodologi Penelitian Klinis Edisi ke-4 [Fundamentals of Clinical Research Methodology 4th Edition]. Jakarta: SagungSeto; 2011
  12. Frye JL, Thompson DF. (1993). Drug–induced thrombocytosis. Journal of Clinical Pharmacy and Therapeutics, 18(1), 45–48. https://doi.org/10.1111/j.1365-2710.1993.tb00565.x
  13. George JN, Aster RH. (2009). Drug-induced thrombocytopenia: Pathogenesis, evaluation, and Management.Hematology, 2009(1), 153–158. https://doi.org/10.1182/asheducation-2009.1.153
  14. Akbar, M. I., & Ali, L. (2020). Kajian Kebutuhan Tenaga Dokter Umum Dengan Menggunakan Metode Workload Indicator Staff Need (WISN) Di Poli Umum Dan Unit Gawat Darurat (UGD) Rsud Kabupaten Buton Utara. Miracle Journal of Public Health, 3(2), 153-162.
  15. Apriliani, A. Perbedaan Jumlah Trombosit, Leukosit dan Nilai Hematokrit pada Pasien DBD Berdasarkan Infeksi Primer dan Sekunder di RSD dr. A. Dadi Tjokrodipo Tahun 2020-2021 [Differences in Platelet Counts, Leukocytes, and Hematocrit Values in DHF Patients Based on Primary and Secondary Infections at RSD dr.A. Dadi Tjokrodipo 2020-2021] [tesis]. Lampung: Fakultas Teknologi Laboratorium Medis Politeknik Kesehatan Tanjungkarang.
  16. Siti Setiati, Alwi I, Sudoyo AW, Simadibrata MK, Setiyohadi B, Syam AF. Buku Ajar Ilmu Penyakit Dalam Jilid I Edisi VI [Textbook of Internal Medicine Volume I Edition VI]. Jakarta: InternaPublishing; 2014
  17. Stevens CD, Miller LE. Clinical Immunology and Serology A Laboratory Perspective 4th Edition (pp. 92-96). Philadelphia: F.A Davis Company; 2017
  18. KhurramM, QayyumW, HassanSJ, MumtazS, BushraHT, UmarM. (2014). Dengue hemorrhagic fever: Comparison of patients with primary and secondary infections. Journal of Infection and Public Health, 7(6), 489–495. https://doi.org/10.1016/j.jiph.2014.05.005
  19. Tirtadevi SN, Riyanti R, Wisudanti DD. Korelasi Jumlah Trombosit dan Kadar Hematokrit terhadap Tingkat Keparahan Pasien Demam Berdarah Dengue di RSD dr. Soebandi Jember [Correlation of Platelet Count and Hematocrit Levels to the Severity of Dengue Hemorrhagic Fever Patients at RSD dr. Soebandi Jember] . Journal of Agromedicine and Medical Sciences. 2021. 7(3): 156-161.
  20. Pusparini. Kadar hematokrit dan Trombosit Sebagai Indikator Diagnosis Infeksi Dengue Primer dan Sekunder [Hematocrit and Platelet Levels as Diagnostic Indicators for Primary and Secondary Dengue Infection] . Jurnal Kedokteran Trisakti. 2004. 24(2): 51-56.